IDOGEN — Idogen AB Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- SEK12.58m
- SEK9.60m
Annual balance sheet for Idogen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 61.6 | 26 | 47 | 15.6 | 5.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.706 | 0.867 | 0.975 | 1.27 | 2.67 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 63 | 27.7 | 48.7 | 21.9 | 8.99 |
| Net Property, Plant And Equipment | 4.66 | 3.44 | 2.12 | 1.21 | 0 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 71.7 | 31.2 | 50.8 | 23.1 | 9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.7 | 12.9 | 10.2 | 12.1 | 5.38 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 20.7 | 12.9 | 10.2 | 12.1 | 5.38 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 51 | 18.3 | 40.6 | 11 | 3.61 |
| Total Liabilities & Shareholders' Equity | 71.7 | 31.2 | 50.8 | 23.1 | 9 |
| Total Common Shares Outstanding |